{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:48:56Z","timestamp":1782604136212,"version":"3.54.5"},"reference-count":24,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1507\/endocrj.k10e-166","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T05:20:21Z","timestamp":1288934421000},"page":"7-12","source":"Crossref","is-referenced-by-count":12,"title":["Transition of thyroid autoantibodies by rituximab treatment for thyroid MALT lymphoma"],"prefix":"10.1507","volume":"58","author":[{"given":"Toshio","family":"Kahara","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Iwaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Kaya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Kurokawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Ishikura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Usuda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Staunton MD, Greening WP (1973) Clinical diagnosis of thyroid cancer. <i>Br Med J<\/i> 4: 532-535.","DOI":"10.1136\/bmj.4.5891.532"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Thieblemont C, Mayer A, Dumontet C, Barbier Y, Callet-Bauchu E, Felman P, Berger F, Ducottet X, Martin C, Salles G, Orgiazzi J, Coiffier B (2002) Primary thyroid lymphoma is a heterogeneous disease. <i>J Clin Endocrinol Metab<\/i> 87: 105-111.","DOI":"10.1210\/jcem.87.1.8156"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200005000-00001"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Holm LE, Blomgren H, L&ouml;whagen T (1985) Cancer risks in patients with chronic lymphocytic thyroiditis. <i>N Engl J Med<\/i> 312: 601-604.","DOI":"10.1056\/NEJM198503073121001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Isaacson PG (1997) Lymphoma of the thyroid gland. <i>Curr Top Pathol<\/i> 91: 1-14.","DOI":"10.1007\/978-3-642-60531-4_1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Maloney DG, Grillo-L&oacute;pez AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA, Janakiraman N, Foon KA, Liles TM, Dallaire BK, Wey K, Royston I, Davis T, Levy R (1997) IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin&rsquo;s lymphoma. <i>Blood<\/i> 90: 2188-2195.","DOI":"10.1182\/blood.V90.6.2188"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Davis TA, Grillo-L&oacute;pez AJ, White CA, McLaughlin P, Czuczman MS, Link BK, Maloney DG, Weaver RL, Rosenberg J, Levy R (2000) Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin&rsquo;s lymphoma: safety and efficacy of re-treatment. <i>J Clin Oncol<\/i> 18: 3135-3143.","DOI":"10.1200\/JCO.2000.18.17.3135"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf155"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. El Fassi D, Nielsen CH, Bonnema SJ, Hasselbalch HC, Heged&uuml;s L (2007) B lymphocyte depletion with the monoclonal antibody rituximab in Graves&rsquo; disease: a controlled pilot study. <i>J Clin Endocrinol Metab<\/i> 92: 1769-1772.","DOI":"10.1210\/jc.2006-2388"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. El Fassi D, Clemmensen O, Nielsen CH, Silkiss RZ, Heged&uuml;s L (2007) Evidence of intrathyroidal B-lymphocyte depletion after rituximab therapy in a patient with Graves&rsquo;disease. <i>J Clin Endocrinol Metab<\/i> 92: 3762-3763.","DOI":"10.1210\/jc.2007-1238"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.49.2821"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. El Fassi D, Banga JP, Gilbert JA, Padoa C, Heged&uuml;s L, Nielsen CH (2009) Treatment of Graves&rsquo; disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies. <i>Clin Immunol<\/i> 130: 252-258.","DOI":"10.1016\/j.clim.2008.09.007"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Raterman HG, Simsek S, Lems WF, Meesters EW, Dijkmans BA, Nurmohamed MT (2009) Rituximab and thyroid function. <i>Arch Intern Med<\/i> 169: 1073-1074.","DOI":"10.1001\/archinternmed.2009.116"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02325"},{"key":"15","unstructured":"15. Romaldini JH, Biancalana MM, Figueiredo DI, Farah CS, Mathias PC (1996) Effect of L-thyroxine administration on antithyroid antibody levels, lipid profile, and thyroid volume in patients with Hashimoto&rsquo;s thyroiditis. <i>Thyroid<\/i> 6: 183-188."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tamura K, Shimaoka K, Friedman M (1981) Thyroid abnormalities associated with treatment of malignant lymphoma. <i>Cancer<\/i> 47: 2704-2711.","DOI":"10.1002\/1097-0142(19810601)47:11<2704::AID-CNCR2820471129>3.0.CO;2-G"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2007.0433"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K08E-355"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.085"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Isobe K, Kagami Y, Higuchi K, Kodaira T, Hasegawa M, Shikama N, Nakazawa M, Fukuda I, Nihei K, Ito K, Teshima T, Matsuno Y, Oguchi M; Japan Radiation Oncology Group (2007) A multicenter phase II study of local radiation therapy for stage IEA mucosa-associated lymphoid tissue lymphomas: a preliminary report from the Japan Radiation Oncology Group (JAROG). <i>Int J Radiat Oncol Biol Phys<\/i> 69: 1181-1186.","DOI":"10.1016\/j.ijrobp.2007.04.029"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1210\/er.15.6.788"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607113350206"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yu S, Dunn R, Kehry MR, Braley-Mullen H (2008) B cell depletion inhibits spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. <i>J Immunol<\/i> 180: 7706-7713.","DOI":"10.4049\/jimmunol.180.11.7706"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland R, Gottlieb PA, Marks JB, McGee PF, Moran AM, Raskin P, Rodriguez H, Schatz DA, Wherrett D, Wilson DM, Lachin JM, Skyler JS; Type 1 Diabetes TrialNet Anti-CD20 Study Group (2009) Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. <i>N Engl J Med<\/i> 361: 2143-2152.","DOI":"10.1056\/NEJMoa0904452"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/58\/1\/58_K10E-166\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:54:06Z","timestamp":1618296846000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/58\/1\/58_K10E-166\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k10e-166","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}